Evidence map›Paper›PMID 40861113›Full record

ArticleTransboundary and emerging diseases2025

Use of Subtherapeutic Tylvalosin Against

Leonardo Teófilo Toledo, Richard Costa Polveiro, Caio Augustus Diamantino, Gustavo Manoel Rigueira Simão, Carlos Eduardo Real Pereira, Eduardo de Freitas Costa, Maria Aparecida Scatamburlo Moreira, Fernanda Simone Marks

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Leonardo Teófilo ToledoDepartment of Veterinary Medicine, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil.ORCID https://orcid.org/0009-0008-8169-9074
Richard Costa PolveiroDepartment of Veterinary Medicine, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil.ORCID https://orcid.org/0000-0002-1714-9720
Caio Augustus DiamantinoDepartment of Veterinary Medicine, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil.
Gustavo Manoel Rigueira SimãoAgroceres PIC Company, Rio Claro 13502-741, São Paulo, Brazil.
Carlos Eduardo Real PereiraDepartment of Veterinary Medicine, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil.ORCID https://orcid.org/0000-0002-3701-5076
Eduardo de Freitas CostaDepartment of Epidemiology, Bioinformatics and Animal models, Wageningen Bioveterinary Research, Lelystad, Flevoland, Netherlands.ORCID https://orcid.org/0000-0002-9483-0800
Maria Aparecida Scatamburlo MoreiraDepartment of Veterinary Medicine, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil.ORCID https://orcid.org/0000-0002-6902-2502
Fernanda Simone MarksDepartment of Veterinary Medicine, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil.ORCID https://orcid.org/0000-0002-0911-5731

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzootic pneumonia (EP) caused by

Indexed as

Anti-Bacterial AgentsDysbiosisMicrobiotaMycoplasma hyopneumoniaePneumonia of Swine, MycoplasmalTylosinAnimalsFemaleLungRNA, Ribosomal, 16SSwineAnti-Bacterial AgentsRNA, Ribosomal, 16STylosintylvalosinantibioticsenzootic pneumoniaexperimental challengemicrobiotarespiratory diseaseUFV01

Identifiers

PMID40861113
PMCPMC12377971

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.